2007, Number 08
<< Back Next >>
Ginecol Obstet Mex 2007; 75 (08)
Catecholamines level variation during pregnancy in women with diabetes and preeclampsia
Hernández-Valencia M, Rivera MAM, Vargas LC, Páez AJA, Vargas GA, Zárate A
Language: Spanish
References: 17
Page: 454-458
PDF size: 147.39 Kb.
ABSTRACT
Background: In obstetrical service it is frequent to find women with acute renal failure during second trimester of pregnancy. Main causes are related to hypertensive alterations, hemorrhage, sepsis, intrinsic renal disease and some rare disorders that produce high maternal morbidity and mortality.
Objetive: To evaluate changes of adrenal function in pregnancy as well as its associated repercussions in diabetic and preeclamsic patients.
Patients and methods: Prospective study in 56 patients. Groups included women with normal pregnancy, patients with diabetes type 2, and women with preeclampsia. It was requested basic exams and samples from urine of 24 h for catecholamines determinations; as well as after two months of delivery. Catecholamines were measured with Bertler immune-fluorescent procedure.
Results: Levels of catecholamines has statistically significant difference in all groups of study during the gestation. There was high quantity in the group of patients that developed preeclampsia 4535.5 ± 356.4 µg/24 h (
p ‹ 0.05), compared with 31.2 ± 9.2 µg/24 h in normal pregnancy; however, those with diabetes has a trend to increas 45.6 ± 3.7 µg/24 h, without statistical differences. Two months after pregnancy levels shown 17.1 ± 4.9 µg/24 h in normal pregnancy group, with preeclampsia 17.2 ± 8.7 µg/24 h, and mild permanent increase 33.8 ± 4.7 µg/24 h in the group with diabetes (
p = 0.537).
Conclusions: An important catecholamines elevation is related with progress or severity of preeclampsia, and could be due to less adrenal injury associated with pregnancy, and contribute to renal failure. Llonger studies are necessary to evaluate this approach in renal function.
REFERENCES
Drakeley AJ, Le Roux PA, Anthony J, Penny J. Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. Am J Obstet Gynecol 2002;5:253-6.
Pertuiset N, Grunfeld JP. Acute renal failure in pregnancy. Baillieres Clin Obstet Gynaecol 1994;8:333-51.
Naqvi R, Akhtar F, Ahmed E, Shaikh R, et al. Acute renal failure of obstetrical origin during 1994 at one center. Ren Fail 1996;18:681-3.
Díaz de León PM, Aristondo MG. Insuficiencia renal aguda. Nefrol Mex 1990;11(2):62-69.
Grunfeld JP, Pertuiset N. Acute renal failure in pregnancy: 1987. Am J Kidney Dis 1987;9:359-62.
Davison KM. Kidney function in pregnant women. Am J Kidney Dis 1987;9:248-52.
Krane NK. Acute renal failure in pregnancy. Arch Intern Med 1988;148:2347-57.
Sens YA, Miorin LA, Silva HG, Malheiros DM, et al. Acute renal failure due to hemolytic uremic syndrome in adult patients. Ren fail 1997;19:279-82.
Ventura JE, Villa M, Mizraji R, Ferreiros R. Acute renal failure in pregnancy. Ren Fail 1997;19:217-20.
Sibai BM, Villar MA, Mabie M. Acute renal failure in hypertensive disorders of pregnancy. Am J Obstet Gynecol 1990;162:777-83.
Greco BA, Breyer JA. The natural history of renal antery stenosis: who slould be evaluated for suspected ischemic nephropathy? Semin Nephrol 1996;16:2-11.
Dunne FP, Chowdhury TA, Hartland A, Smith T, et al. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy. QJM 1999;92:451-4.
Tissier I, Dreyfus M, Woehl-Jaegle ML, el Khadime A, et al. Pregnancy after renal transplantation. Obstetrical follow up and long term outcome of the renal graft. J Gynecol Obstet Biol Reprod 1999;28:550-5.
Ekbom P, DammP, Feldt-Rasmussen B, Feldt-Rasmussen U, et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001;24:1739-44.
Feig D, Palda VA. Type 2 diabetes: a growing concern. Lancet 2002;359:1690-2.
Tietz NW. Química clínica. 1a ed. México: McGraw-Hil Interamericana, 1972;pp:593-5.
Reece EA, Sivan E, Francis G, Homko CJ. Pregnancy outcomes among women with and without microvascular disease (White’s classes B to R) versus non-diabetic controls. Am J Perinatol 1998;15:549-55.